(Q31399140)

2 July 2017

Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data (English)

1 reference

2 July 2017

Tummala S

1

1 reference

PubMed ID

10480450

2 July 2017

Svec F

series ordinal

2

1 reference

2 July 2017

1 July 1999

1 reference

2 July 2017

Clinical Biochemistry

1 reference

2 July 2017

32

1 reference

2 July 2017

5

1 reference

2 July 2017

355-361

1 reference

Dehydroepiandrosterone sulfate and aging

2 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Effects of acute administration of dehydroepiandrosterone-sulfate on adipose tissue mass and cellularity in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Characterization and measurement of dehydroepiandrosterone sulfate in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Development and regeneration of the nervous system: a role for neurosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Biosynthesis and assay of neurosteroids in rats and mice: functional correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Antidepressant and cognition-enhancing effects of DHEA in major depression.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

An open study of dehydroepiandrosterone in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

The actions of exogenous dehydroepiandrosterone in experimental animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Case report: amelioration of insulin resistance in diabetes with dehydroepiandrosterone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

The effect of DHEAS on influenza vaccination in aging adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

Enzymology of human cytosolic sulfotransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2899%2900021-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9120(99)00021-1

1 reference

2 July 2017

1 reference

PubMed ID

10480450